Phase I/II clinical trial of verification for the safety and efficacy of Amitose-Bis-glyceryl ascorbate-containing cream in renal cell carcinoma patients treated by sunitinib

Not Applicable

• Conditions: Renal cell carcinoma

• Registration Number: JPRN-UMIN000027209
• Lead Sponsor: Kobe University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-12-27
• Study Completion: 2022-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients in whom the underlying disease is a dermatological disease at palmar and planter region at initiation of sunitinib treatment 2) Patients who are applied external medicine not involving 10% urea and heparinoid-containing cream to palmar and planter region at initiation of sunitinib treatment 3) Patients who are not able to apply 10% urea or heparinoid-containing cream to palmar and planter region 4) Patients with HFSR of grade 1 or higher at initiation of sunitinib treatment 5) Patients with infections which needs systemic treatment 6) Patients with severe hepatic disorder 7) Patients with severe renal disorder 8) Patients who are lack of felicity

Study & Design

• Study Type: Interventional
• Study Design: Not specified